Although tadalafil is already present as Cialis ... Adcirca (tadalafil) has been approved with a recommended dose of 40 mg, as the first once-daily phosphodiesterase type 5 (PDE5) inhibitor for the treatment of pulmonary arterial hypertension (PAH).
- Tadalafil Information for Consumers
- Tadalafil Information for Healthcare Professionals (includes dosage details)
- Side Effects of Tadalafil (detailed)
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Posted 20 Apr 2013 • 2 answers
Pulmonary Hypertension - I have just been diagnosed with PAH and the only drug I have have been put?
Posted 10 Jan 2014 • 2 answers
Posted 29 Apr 2014 • 3 answers
Posted 19 May 2014 • 1 answer
Posted 30 Apr 2015 • 1 answer